Vensica Medical ^{For Profit}

Vensica is a company that is developing next-generation neurotoxins for urology. The company has raised $19 million to take them through phase II. The founders of the company are Avner Geva, who is the CEO and a serial entrepreneur in the life sciences and Avi Eftel, who is the CTO and has extensive experience in leading start-ups from inception to go-to-market. The investors of the company are global corporates and VC's. The website offers a subscription to hear from the company and a contact form to drop a message. Contact_info: No contact information provided.